JP2014095726A5 - - Google Patents

Download PDF

Info

Publication number
JP2014095726A5
JP2014095726A5 JP2014018906A JP2014018906A JP2014095726A5 JP 2014095726 A5 JP2014095726 A5 JP 2014095726A5 JP 2014018906 A JP2014018906 A JP 2014018906A JP 2014018906 A JP2014018906 A JP 2014018906A JP 2014095726 A5 JP2014095726 A5 JP 2014095726A5
Authority
JP
Japan
Prior art keywords
specimen
saliva
gastrointestinal
urine
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014018906A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014095726A (ja
JP5837630B2 (ja
Filing date
Publication date
Priority claimed from GBGB0720113.0A external-priority patent/GB0720113D0/en
Application filed filed Critical
Publication of JP2014095726A publication Critical patent/JP2014095726A/ja
Publication of JP2014095726A5 publication Critical patent/JP2014095726A5/ja
Application granted granted Critical
Publication of JP5837630B2 publication Critical patent/JP5837630B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014018906A 2007-10-15 2014-02-03 ガンの診断、予測、および予後試験 Expired - Fee Related JP5837630B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0720113.0 2007-10-15
GBGB0720113.0A GB0720113D0 (en) 2007-10-15 2007-10-15 Diagnostic, prognostic and predictive testing for cancer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010529444A Division JP5559056B2 (ja) 2007-10-15 2008-10-15 ガンの診断、予測、および予後試験

Publications (3)

Publication Number Publication Date
JP2014095726A JP2014095726A (ja) 2014-05-22
JP2014095726A5 true JP2014095726A5 (enExample) 2014-07-24
JP5837630B2 JP5837630B2 (ja) 2015-12-24

Family

ID=38813827

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010529444A Expired - Fee Related JP5559056B2 (ja) 2007-10-15 2008-10-15 ガンの診断、予測、および予後試験
JP2014018906A Expired - Fee Related JP5837630B2 (ja) 2007-10-15 2014-02-03 ガンの診断、予測、および予後試験

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010529444A Expired - Fee Related JP5559056B2 (ja) 2007-10-15 2008-10-15 ガンの診断、予測、および予後試験

Country Status (11)

Country Link
US (3) US8512716B2 (enExample)
EP (1) EP2208070B1 (enExample)
JP (2) JP5559056B2 (enExample)
CN (1) CN101896819A (enExample)
AU (1) AU2008313459B2 (enExample)
CA (1) CA2702653A1 (enExample)
DK (1) DK2208070T3 (enExample)
ES (1) ES2395890T3 (enExample)
GB (1) GB0720113D0 (enExample)
PT (1) PT2208070E (enExample)
WO (1) WO2009050461A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0921873D0 (en) * 2009-12-15 2010-01-27 Cytosystems Ltd Assay
MX382244B (es) * 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
WO2014179959A1 (en) * 2013-05-09 2014-11-13 The Procter & Gamble Company Method and system for assessing health condition
CN103592444A (zh) * 2013-11-27 2014-02-19 中国人民解放军沈阳军区总医院 一种检测乳腺癌中cyclin G1蛋白表达并进行预后评估的方法
US9857354B2 (en) 2014-06-01 2018-01-02 Novazoi Theranostics, Inc. Compositions and methods for prognosis and treatment of neoplasm
WO2016131875A1 (en) * 2015-02-17 2016-08-25 Biontech Diagnostics Gmbh Methods and kits for the molecular subtyping of bladder cancer
ES2911415T3 (es) 2015-06-08 2022-05-19 Arquer Diagnostics Ltd Métodos y kits
WO2016198833A2 (en) 2015-06-08 2016-12-15 Arquer Diagnostics Limited Methods
CN105986034A (zh) * 2016-06-15 2016-10-05 南京卡迪睿伯生物技术有限公司 一组胃癌基因的应用
CN108344868B (zh) * 2018-01-23 2020-05-15 郑州大学第一附属医院 人组蛋白H3 Ser10和Ser28在鉴定人早期胚胎的发育分期中的应用
CN108344867B (zh) * 2018-01-23 2020-05-15 郑州大学第一附属医院 人组蛋白H3 Ser10和Ser28在鉴定人卵母细胞成熟分期中的应用
CN111187833A (zh) * 2018-11-14 2020-05-22 上海生物芯片有限公司 Plk1和bub1b基因联合作为肺癌生物标志物的用途
GB201820867D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
CN109988708B (zh) * 2019-02-01 2022-12-09 碳逻辑生物科技(中山)有限公司 一种用于对患有结肠直肠癌的患者进行分型的系统
CN110846413B (zh) * 2019-11-23 2023-05-26 中南大学湘雅三医院 Mafg/mafg-as1/mafg正反馈环作为靶位点检测试剂的应用
CN114019163B (zh) * 2021-11-02 2024-07-23 复旦大学附属中山医院 基于活化b细胞表达的结肠癌预后诊断用标记物及其用途
EP4473477A4 (en) * 2022-02-01 2026-01-14 4D Path Inc IMAGE-BASED DISEASE CHARACTERIZATION SYSTEMS AND METHODS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4329177A1 (de) * 1993-08-30 1995-03-02 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Klonierung eines neuen Mitgliedes der Familie der Serin-Threonin-Kinasen
DE19915057A1 (de) * 1999-04-01 2000-10-19 Forschungszentrum Borstel Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung
EP1422526A1 (en) 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
GB0323225D0 (en) * 2003-10-03 2003-11-05 Ncc Technology Ventures Pte Lt Materials and methods relating to breast cancer classification
US7871769B2 (en) * 2004-04-09 2011-01-18 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
US20050260653A1 (en) * 2004-04-14 2005-11-24 Joshua Labaer Nucleic-acid programmable protein arrays
EP1805676A1 (en) * 2004-09-22 2007-07-11 Tripath Imaging, Inc. Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
KR20070107034A (ko) * 2005-02-18 2007-11-06 아스트라제네카 아베 Ｃｈｋ1 억제제에 대한 반응성의 결정 방법
ATE456053T1 (de) * 2005-12-30 2010-02-15 Ventana Med Syst Inc Na+, k+-atpase-expression bei zervixdysplasie und krebs
WO2007077435A1 (en) * 2005-12-30 2007-07-12 Astex Therapeutics Limited Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
EP3101407A4 (en) Protectant for electron microscope observation of hydrated biological sample, kit for electron microscope observation, method for observation, diagnosis, evaluation, or quantification by electron microscope, and sample stage
EP3259067A4 (en) Devices for biological sample collection and analysis and methods of use thereof
EP3314234A4 (en) IMAGES FOR FLUORESCENCE ORGANIC SAMPLES AND METHODS
EP3175247A4 (en) Instrument for analyzing biological samples and reagents
EP3345001A4 (en) METHOD AND DEVICES FOR ANALYTICAL COLLECTION, EXTRACTION, CONCENTRATION AND DETECTION FOR CLINICAL APPLICATIONS
WO2015195949A3 (en) Methods, compositions, and devices for rapid analysis of biological markers
CL2017000935S1 (es) Instrumento para preparación de muestras o secuenciación.
JP2011520451A5 (enExample)
EP3080585A4 (en) Biosensors for biological or chemical analysis and methods of manufacturing the same
WO2015176066A3 (en) Lpa-associated protein and rna expression
IL248299B (en) A method and kit for determining the tissue or cell origin of dna
IL283398A (en) A tissue specimen collector for use in biopsy
PL3232777T3 (pl) Przechowywanie i transport próbki biologicznej ex vivo obejmujące zastosowanie ultradźwięków
AU2018290809A1 (en) Biomarkers for the diagnosis and treatment of fibrotic lung disease
EP3705052C0 (en) BIOLOGICAL SAMPLE COLLECTION DEVICE
IT201600073964A1 (it) Nanointerruttore basato su nucleotidi e metodi per la rilevazione di anticorpi e altri analiti
EP3567098A4 (en) AUTOMATIC PURIFICATION SYSTEM AND BIOLOGICAL SAMPLE PURIFICATION PROCESS
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
PL3285654T3 (pl) Sposób pobierania próbek mikroorganizmów, urządzenie do pobierania próbek mikroorganizmów oraz zestaw do pobierania próbek zawierający takie urządzenie do pobierania próbek
WO2015054700A3 (en) Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof
EP3584307A4 (en) CELL CULTURE CONTAINER, SAMPLE CELL FOR OBSERVATION, AND CELL CULTURE PROCESS
WO2015200833A3 (en) COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2)
EP3152582A4 (en) Methods of detecting biological prints, fluids or analytes therein using porous semiconductor substrates
DK3161165T3 (da) Fremgangsmåde til diagnosticering af subklinisk og klinisk akut afstødning ved analyse af prædiktive gensæt, terapeutisk middel til anvendelse ved behandlingen og kits til at bestemme ekspressionen
EP3407907A4 (en) WNT COMPOSITIONS AND METHOD FOR SERUM-FREE SYNTHESIS